N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.83p
   
  • Change Today:
    -0.025p
  • 52 Week High: 3.07
  • 52 Week Low: 0.80
  • Currency: UK Pounds
  • Shares Issued: 268.78m
  • Volume: 823,510
  • Market Cap: £2.22m

Latest ShareCast News

N4 Pharma shares jump on latest Nuvec developments

By Josh White

Date: Thursday 15 Feb 2024

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.

N4 Pharma's Nuvec granted patent in India

By Josh White

Date: Friday 19 Jan 2024

(Sharecast News) - N4 Pharma, a pharmaceutical company developing the cancer vaccine delivery system Nuvec, announced on Friday that it has received confirmation from the University of Queensland regarding the granting of its patent for Nuvec in India.

N4 Pharma subsidiary agrees work programme for glaucoma treatment

By Josh White

Date: Tuesday 16 Jan 2024

(Sharecast News) - N4 Pharma announced a significant development through its subsidiary Nanogenics on Tuesday, after Nanogenics inked a contract to initiate the formulation and sequence selection work for its ECP105 product, aimed at pre-clinical studies at King's College, London.

N4 Pharma reports progress in Nuvec clinical res... 08-Jan-2024 ShareCast
N4 Pharma upbeat on recent Nuvec developments 18-Dec-2023 ShareCast
N4 Pharma posts optimistic Nuvec research update 07-Dec-2023 ShareCast
N4 Pharma picks up controlling interest in Nanog... 28-Sep-2023 ShareCast
N4 Pharma reports progress with siRNA work 18-Apr-2023 ShareCast
N4 Pharma shares tumble following placing, broke... 18-Nov-2022 ShareCast
N4 Pharma reports success in recent 'Nuvec' test... 04-Oct-2022 ShareCast
N4 Pharma reduces losses as Nuvec development co... 29-Sep-2022 ShareCast
N4 Pharma upbeat on latest tumour suppression st... 15-Jul-2022 ShareCast
N4 Pharma outlines work plan after 'encouraging'... 25-Jan-2022 ShareCast
N4 upbeat on cancer treatment progress, vaccine ... 13-Dec-2021 ShareCast
N4 Pharma granted Europe patent with China equiv... 01-Oct-2021 ShareCast
N4 Pharma losses widen as it works on commercial... 24-Feb-2021 ShareCast
N4 Pharma shares surge on latest from Nanomerics... 03-Dec-2020 ShareCast
N4 Pharma working with Nanomerics on oncology pr... 09-Nov-2020 ShareCast
N4 Pharma plunges as Covid-19 progress stalls 14-Sep-2020 ShareCast
N4 Pharma chooses Ardena as contract manufacturi... 01-Sep-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.83p
Change Today -0.025p
% Change -2.94 %
52 Week High 3.07
52 Week Low 0.80
Volume 823,510
Shares Issued 268.78m
Market Cap £2.22m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average
35.85% below the sector average35.85% below the sector average35.85% below the sector average35.85% below the sector average35.85% below the sector average
Value
35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average35.93% below the market average
35.85% below the sector average35.85% below the sector average35.85% below the sector average35.85% below the sector average35.85% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
16:06 2,823 @ 0.80p
16:06 166 @ 0.80p
11:08 83,000 @ 0.85p
09:31 20,671 @ 0.86p
08:38 100,000 @ 0.81p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page